INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)

$1.87 -0.01 (-0.5319%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 66

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) News Sources

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma

10-08-2026

yahoo.com

external link

Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer

10-08-2026

yahoo.com

external link

Swedish Orphan Biovitrum (OM:SOBI) Following Its Lacutamab Deal And The Undervalued Narrative

15-08-2026

yahoo.com

external link

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

10-08-2026

yahoo.com

external link

Sobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III

10-08-2026

pharmaceutical-technology.com

external link

Innate Pharma Announces Conference Call and Webcast

14-08-2026

yahoo.com

external link

Innate Pharma Secures €30M, Extends Cash Runway Into 2028

14-08-2026

marketbeat.com

external link

Innate Pharma SA (IPHA) (Q2 2026) Earnings Call Highlights: Strategic Partnerships and Pipeline ...

17-08-2026

yahoo.com

external link

Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

02-09-2026

yahoo.com

external link

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

10-09-2026

yahoo.com

external link

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) Sentiment Trend

0 25 50 75 100 72 61 32 69 74 50 84 81 78 57 10-08-2026 15-08-2026 14-08-2026 17-08-2026 02-09-2026 10-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) FAQs

toggle

What is the current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?

The current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is $1.87.


toggle

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) absolute price change since previous trading day?

The absolute price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is $-0.01.


toggle

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) percentage price change since previous trading day?

The percentage price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is -0.5319%.


toggle

What is the most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?

The most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is 66 out of 100.


toggle

What is the most recent average sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?

The most recent sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is .


SEC-8K** Filing Available For INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

PHAR (Pharming Group N.V. ADR)
AAPG (Ascentage Pharma Group Intl ADR)
AKTX (Akari Therapeutics ADR)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.